5 Good reasons why Cognitive Behavioral Therapy for Insomnia will work

CBT-I or Cognitive Behavioral Therapy for Insomnia is currently the gold standard in treating insomnia. It has achieved widespread scientific recognition for treating insomnia.

What is CBT-I?

Cognitive Behavior therapy for Insomnia is a safe, effective way of treating insomnia. Here are 5 reasons why CBT-I is effective:

  1. Drugless. CBT-I focuses on basically two parts namely the “Cognitive” Part and the “Behavior” part. The “Cognitive” Part focusses on how we think and feel about sleep and how we manage our ability to sleep. The “Behavioral” part of CBT-I helps the client to adopt effective and healthy behaviours or habits which are based on the science and physiology of sleep. There are no drugs involved.
  2. Safe: Cognitive Behavior Therapy is used in a safe environment with your therapist. Your treatment is based on certain milestones which you and your therapist will determine together based on sleep science and your individual sleep goals. Your therapist will guide you every step of the way.
  3. Delivered on in any platform: CBT-I is just as effective during face to face consultations as it is during on-line consultations
  4. Clinically Effective: Clients who have undergone CBT-I get more restorative sleep than those on the mainstream sleep medication. Clients also experience lasting benefits because of CBT-I focuses on the “tools” of how to sleep better.[1]
  5. Cost-effective. Total treatment cost equates to about $200 to $220 in the first 6 months. However, the advantages of CBT-I is that the effects are long-lasting, which means that there are very little ongoing treatment costs. CBT-I has, therefore, the potential to produce long term savings.[2]

If you suffer from insomnia and would like to go to sleep and stay asleep in a natural, long-lasting way, contact your Arkel Sleep Health Consulting or ask your doctor for a referral.

[1]Jacobs, Gregg D.; Pace-Schott, EF; Stickgold, R; Otto, MW (2004). “Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: A Randomized Controlled Trial and Direct Comparison”. Archives of Internal Medicine. 164 (17): 1888–96. PMID15451764. Lay summary – American Family Physician (July 15, 2005).